phenytoin has been researched along with resorufin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bürck, C; Hagemeyer, CE; Knoth, R; Meyer, RP; Schwab, R | 1 |
| Bingaman, W; Ghosh, C; Gonzalez-Martinez, J; Hossain, M; Janigro, D; Khan, S; Marchi, N; Mishra, S; Najm, I | 1 |
2 other study(ies) available for phenytoin and resorufin
| Article | Year |
|---|---|
7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver.
Topics: Animals; Anticonvulsants; Blotting, Western; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Assays; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxazines; Oxidation-Reduction; Phenytoin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone | 2010 |
Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model.
Topics: Anticonvulsants; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Brain; Cells, Cultured; Cytochrome P-450 CYP3A; Endothelial Cells; Epilepsy; Humans; Mifepristone; Models, Biological; Oxazines; Peroxisome-Targeting Signal 1 Receptor; Phenytoin; Receptors, Glucocorticoid; RNA, Small Interfering; Sucrose | 2018 |